article thumbnail

The quest for quality continues

Express Pharma

It is encouraging to see that the Indian pharmaceutical sector is making significant strides towards becoming a global benchmark for quality through capability building, process improvements, talent development, digitalisation, and fostering a quality-first mindset.”

article thumbnail

Unlocking Personalized Patient Support: Five AI Insights

Pharma Leaders

AI Enables Improved Quality and Compliance: AI facilitates the analysis of all patient interactions, significantly improving the identification of compliance risks and opportunities for process improvement.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

9th Advanced GMP Workshop 2024 was organised by IPA

Express Pharma

It is encouraging to see that the Indian pharmaceutical sector is making significant strides towards becoming a global benchmark for quality through capability building, process improvements, talent development, digitalisation, and fostering a quality-first mindset.”

article thumbnail

AI-powered orchestration: Bringing the benefits to personalized therapy

Pharmaceutical Technology

AI can transform cell and gene therapy (CGT) orchestration by automating manual processes, improving productivity, enhancing supply chain visibility and improving scalability.

article thumbnail

How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing

Drug Patent Watch

Legal and Patent Review Engage legal experts to conduct a comprehensive review of the drug’s patent portfolio, including: Validity of existing patents Potential for patent term extensions Ongoing or potential patent litigation Market Analysis Perform a detailed market analysis to understand: Current and projected market size Competitive landscape (..)

article thumbnail

NHC Submits Comments on CMS Draft Guidance for IPAY 2028

Putting Patients First Blog

24 To ensure that listening sessions yield actionable, patient-centered insights, the NHC recommends the following process improvements focused on accessibility, clarity, and broad participation of stakeholders: CMS should provide a minimum of 30 days’ advance notice and allow scheduling flexibility for all listening sessions.

article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

It attributed Indias cost advantage to high-production capacity plants, process improvements, economies of scale, and backward integration in manufacturing. On the pricing of generics, IPA stated, While generics are priced lower than the corresponding brands, it is unfair and unacceptable to link quality with cost.